Market Place
Sourcing Support
All News #Library
Biotech
Touchlight and New England Biolabs Unveil EnClose Cell-free dbDNA
19 Mar 2026 //
PHARMIWEB
Touchlight Unveils Next-Gen DNA Portfolio For Gene Therapies
10 Nov 2025 //
INDPHARMAPOST
Touchlight Expands mbDNA Platform
05 Nov 2025 //
CONTRACTPHARMA
Touchlight unveils mbDNA: A circular ssDNA platform for enhanced
01 Aug 2025 //
EXPRESSPHARMA
Touchlight Wins ISPE Award for dbDNA Manufacturing
14 May 2025 //
PRESS RELEASE
Touchlight Appoints Will Downie As Adviser For Synthetic DNA Growth
28 Jan 2025 //
PHARMAWEB
Touchlight, University of Nottingham Partner to Develop Zika DNA Vaccine
21 Aug 2024 //
PRESS RELEASE
Touchlight joins forces with University of Liverpool for NSCLC vaccine
03 Apr 2024 //
PRESS RELEASE
Touchlight To Supply Enzymatic dbDNA To CPI`s RNA Centre Of Excellence
28 Mar 2024 //
PRESS RELEASE
Touchlight’s enzymatic doggybone DNA used in manufacture of Versameb’s VMB-100
21 Nov 2023 //
BUSINESSWIRE
Curia expands biologics capabilities with access to Touchlight’s doggybone DNA
25 Jul 2023 //
PRESS RELEASE
Touchlight launches its new customer offering of Discovery grade doggybone DNA (dbDNA)
12 Jul 2023 //
PRESS RELEASE
Touchlight Completes Expansion, Creating One of the World’s Largest DNA
24 May 2023 //
BUSINESSWIRE
Touchlight and 20Med partner on vaccine platform
19 Apr 2023 //
PHARMA TIMES
Touchlight secures government grant to support its £14m investment in scale-up DNA manufacturing
29 Mar 2023 //
PRESS RELEASE
Touchlight Cleared by FDA for IND Utilizing Doggybone DNA
28 Feb 2023 //
CONTRACT PHARMA
FDA Accepts Drug Master File, Signifying a New Milestone for Touchlight’s Enzymatic doggybone DNA Technology
24 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.